Effect of Docosahexaenoic Acid (DHA) use on the incidence of eye disease of preterm babies - Trial RBR-523wzcb
Access comprehensive clinical trial information for RBR-523wzcb through Pure Global AI's free database. This phase not specified trial is sponsored by Secretaria Estadual da Saúde de Santa Catarina and is currently Recruitment Completed. The study focuses on Retinopathy of Prematurity.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Registro Brasileiro De Ensaios Clinicos data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
RBR-523wzcb
Recruitment Completed
Trial Details
Registro Brasileiro De Ensaios Clinicos • RBR-523wzcb
Effect of Docosahexaenoic Acid (DHA) use on the incidence of eye disease of preterm babies
Effect of Docosahexaenoic Acid (DHA) supplementation on the incidence of Retinopathy of Prematurity
Study Focus
Interventional
Sponsor & Location
Secretaria Estadual da Saúde de Santa Catarina
Universidade da Região de Joinville
Brazil
Timeline & Enrollment
N/A
Mar 01, 2020
N/A
ICD-10 Classifications
Retinopathy of prematurity
Other proliferative retinopathy
Background retinopathy and retinal vascular changes
Diabetic retinopathy
Retinal disorder, unspecified
Data Source
Registro Brasileiro De Ensaios Clinicos
RBR-523wzcb
Non-Device Trial